J. Max Goodson

Papers

1

Total Citations

14

H-Index

1

About

J. Max Goodson is a pioneering researcher in salivary diagnostics and oral-systemic health, whose work has fundamentally advanced the understanding of how non-invasive biomarkers can reflect systemic disease. His key research areas include salivary biomarkers for metabolic disorders, adolescent obesity, and the oral-systemic connection. Goodson’s major contribution lies in demonstrating that salivary concentrations of glucose, insulin, VEGF-A, and IL-12p70 can serve as reliable surrogates for blood levels, enabling early detection of unhealthy phenotypes. His influential 2016 study on obese Kuwaiti adolescents, which has garnered 14 citations, revealed that salivary biomarkers could identify metabolic dysregulation without needles—a breakthrough for pediatric screening. This work has paved the way for accessible, painless diagnostics in public health settings. Goodson’s research is notable for its translational impact, bridging basic salivary biochemistry with real-world clinical applications. His findings continue to inspire new approaches to non-invasive monitoring of obesity, diabetes, and inflammation, making him a key figure in the evolution of precision medicine through saliva-based testing.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Unhealthy Phenotype as Indicated by Salivary Biomarkers: Glucose, Insulin, VEGF-A, and IL-12p70 in Obese Kuwaiti Adolescents
14 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 15

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago